This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Ingevity (NGVT) Gains on Strong Demand, Capacity Expansion
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
Ingevity (NGVT) Up 10.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Ingevity (NGVT) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Ingevity (NGVT) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's put Ingevity Corporation (NGVT) stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Here's Why Ingevity (NGVT) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts Think Ingevity (NGVT) Could Surge 45%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 44.6% upside potential for Ingevity (NGVT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Should Value Investors Buy AdvanSix (ASIX) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ingevity's (NGVT) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Ingevity (NGVT) gains on actions to increase prices and strong end-market demand in Q1.
Ingevity (NGVT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 45.95% and 11.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Daqo New Energy, Ingevity, AdvanSix and Hawkins
by Zacks Equity Research
Daqo New Energy, Ingevity, AdvanSix and Hawkins have been highlighted in this Industry Outlook article.
Is DAQO New Energy (DQ) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Chemical Specialty Stocks to Escape Industry Challenges
by Anindya Barman
Soft automotive demand and input cost pressure dampen prospects for the Zacks Chemicals Specialty industry. DQ, NGVT, ASIX and HWKN are set to gain from self-help actions.
Ingevity (NGVT) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why You Should Add Ingevity (NGVT) Stock to Your Portfolio
by Zacks Equity Research
Ingevity (NGVT) benefits from strength in its engineered polymers and industrial specialties businesses and actions to drive growth.
Ingevity (NGVT) Down 1.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Ingevity (NGVT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Element Solutions (ESI) Soars 9.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Element Solutions (ESI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Ingevity (NGVT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts Predict a 40% Upside in Ingevity (NGVT): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 39.7% in Ingevity (NGVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Ingevity's (NGVT) Q4 Earnings and Revenues Beat Estimate
by Zacks Equity Research
Ingevity's (NGVT) Q4 results benefit from higher volumes in the Performance Chemicals segment.
Ingevity (NGVT) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 9.86% and 15.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Livent (LTHM) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Livent (LTHM) delivered earnings and revenue surprises of 14.29% and 17.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?